Amedeo Smart

Free Medical Literature Service




  Free Subscription


4 Am J Med
1 Antiviral Res
1 Arch Virol
3 BMC Pediatr
13 BMJ
10 Epidemiol Infect
1 J Immunol
18 J Infect
7 J Virol
1 J Virol Methods
5 Lancet
1 MMWR Morb Mortal Wkly Rep
4 N Engl J Med
9 Pediatrics
2 PLoS Comput Biol
2 PLoS Med
64 PLoS One
10 Proc Natl Acad Sci U S A
1 Vaccine
2 Virology

    Am J Med

  1. HORWITZ RI, Conroy AH, Cullen MR, Colella K, et al
    Long COVID and Medicine's Two Cultures.
    Am J Med. 2022;135:945-949.
    >> Share

  2. FRANCIS Z, Book G, Litvin C, Kalivas B, et al
    The COVID-19 Pandemic and Zinc-Induced Copper Deficiency: An Important Link.
    Am J Med. 2022;135:e290-e291.
    >> Share

  3. WORMSER GP, Flatley CA, Flatley EM, White PA, et al
    Lack of Convincing Evidence That the Widely Used COVID-19 Vaccines Will Produce Herd Immunity.
    Am J Med. 2022;135:e231-e233.
    >> Share

  4. FOX J, Meisenberg B
    The 3-Fold Harms of Compassion Fatigue During COVID-19 Surges.
    Am J Med. 2022;135:e234-e235.
    >> Share

    Antiviral Res

  5. KOMENO T, Furuta Y, Nakajima N, Tani H, et al
    Analysis of the responsible site for favipiravir resistance in RNA-dependent RNA polymerase of influenza virus A/PR/8/34 (H1N1) using site-directed mutagenesis.
    Antiviral Res. 2022 Aug 2:105387. doi: 10.1016/j.antiviral.2022.105387.
    >> Share

    Arch Virol

  6. YANG F, Zhang X, Liu F, Yao H, et al
    Rapid emergence of a PB2 D701N substitution during adaptation of an H9N2 avian influenza virus in mice.
    Arch Virol. 2022 Aug 3. pii: 10.1007/s00705-022-05536.
    >> Share

    BMC Pediatr

  7. POWELL AA, Ireland G, Aiano F, Flood J, et al
    Perceptions of adolescents on the COVID-19 pandemic and returning to school: qualitative questionnaire survey, September 2020, England.
    BMC Pediatr. 2022;22:456.
    >> Share

  8. SOTI KHIABANI M, Mohammadi MS, Ghoreyshi SA, Rohani P, et al
    Acute pancreatitis in 60 Iranian children: do pediatricians follow the new guidelines in diagnosis and management of acute pancreatitis?
    BMC Pediatr. 2022;22:457.
    >> Share

  9. GUAN X, Gao S, Zhao H, Zhou H, et al
    Clinical characteristics of hospitalized term and preterm infants with community-acquired viral pneumonia.
    BMC Pediatr. 2022;22:452.
    >> Share


  10. WARD IL, Bermingham C, Ayoubkhani D, Gethings OJ, et al
    Risk of covid-19 related deaths for SARS-CoV-2 omicron (B.1.1.529) compared with delta (B.1.617.2): retrospective cohort study.
    BMJ. 2022;378:e070695.
    >> Share

  11. LORENZO-REDONDO R, Ozer EA, Hultquist JF
    Covid-19: is omicron less lethal than delta?
    BMJ. 2022;378:o1806.
    >> Share

  12. DYER O
    Covid-19: Ontario hospitals close wards as nursing shortage bites.
    BMJ. 2022;378:o1917.
    >> Share

  13. HERETH B, Tubig P, Sorrels A, Muldoon A, et al
    Long covid and disability: a brave new world.
    BMJ. 2022;378:e069868.
    >> Share

    Covid-19: Staff absences in July surged amid ongoing pressure on hospitals.
    BMJ. 2022;378:o1909.
    >> Share

  15. NELSON B
    What poo tells us: wastewater surveillance comes of age amid covid, monkeypox, and polio.
    BMJ. 2022;378:o1869.
    >> Share

  16. REICHER S, Michie S, West R
    The UK government's "personal responsibility" policy for covid is hypocritical and unsustainable.
    BMJ. 2022;378:o1903.
    >> Share

  17. SAXENA S, Skirrow H, Wighton K
    Vaccinating children aged under 5 years against covid-19.
    BMJ. 2022;378:o1863.
    >> Share

  18. WISE J
    Long covid: Hair loss and sexual dysfunction are among wider symptoms, study finds.
    BMJ. 2022;378:o1887.
    >> Share

  19. KYE WEN TAN N, Jing-Wen C, Tan, Kye Jyn Tan B, et al
    The burden of prolonged smell and taste loss in covid-19.
    BMJ. 2022;378:o1895.
    >> Share

  20. TAN BKJ, Han R, Zhao JJ, Tan NKW, et al
    Prognosis and persistence of smell and taste dysfunction in patients with covid-19: meta-analysis with parametric cure modelling of recovery curves.
    BMJ. 2022;378:e069503.
    >> Share

  21. DYER C
    Covid-19: "Impossible" to be confident that government awarded Randox contracts properly, say MPs.
    BMJ. 2022;378:o1893.
    >> Share

    Learning from complaints during covid-19: discuss risks and benefits before hospital treatment.
    BMJ. 2022;378:o1858.
    >> Share

    Epidemiol Infect

  23. LOSS J, Wurm J, Varnaccia G, Schienkiewitz A, et al
    Transmission of SARS-CoV-2 among children and staff in German daycare centres.
    Epidemiol Infect. 2022;150:e141.
    >> Share

  24. LI R, Li Q, Liu Y, Shen M, et al
    Modelling the impact of universal influenza vaccines on seasonal influenza with different subtypes.
    Epidemiol Infect. 2021;149:e253.
    >> Share

  25. NIELSEN RT, Dalby T, Emborg HD, Larsen AR, et al
    COVID-19 preventive measures coincided with a marked decline in other infectious diseases in Denmark, spring 2020.
    Epidemiol Infect. 2022;150:e138.
    >> Share

  26. AL-SHEHARI WA, Yin YA, Wang X, Wang Y, et al
    Prevalence and surveillance of tuberculosis in Yemen from 2006 to 2018.
    Epidemiol Infect. 2022;150:e146.
    >> Share

    Spatial growth rate of emerging SARS-CoV-2 lineages in England, September 2020-December 2021.
    Epidemiol Infect. 2022;150:e145.
    >> Share

  28. SILVA MJA, Rodrigues YC, Lima KVB, Lima LNGC, et al
    Innate immunity to SARS-CoV-2 infection: a review.
    Epidemiol Infect. 2022;150:e142.
    >> Share

  29. IMPOUMA B, Mboussou F, Farham B, Makubalo L, et al
    COVID-19 vaccination rollout in the World Health Organization African region: status at end June 2022 and way forward.
    Epidemiol Infect. 2022;150:e143.
    >> Share

  30. JANNUZZI P, Panza GA
    Author response to: Letter to Editor in Response to the association between contact with children and the clinical course of COVID-19.
    Epidemiol Infect. 2022;150:e139.
    >> Share

  31. AUSTHOF E, Bell ML, Riddle MS, Catalfamo C, et al
    Persisting gastrointestinal symptoms and post-infectious irritable bowel syndrome following SARS-CoV-2 infection: results from the Arizona CoVHORT.
    Epidemiol Infect. 2022 Jul 8:1-22. doi: 10.1017/S0950268822001200.
    >> Share

  32. SOYEMI E, Soyemi K
    Response to the association between contact with children and the clinical course of COVID-19.
    Epidemiol Infect. 2022;150:e140.
    >> Share

    J Immunol

  33. CIPOLLA EM, Yue M, Nickolich KL, Huckestein BR, et al
    Heterotypic Influenza Infections Mitigate Susceptibility to Secondary Bacterial Infection.
    J Immunol. 2022 Aug 1. pii: jimmunol.2200261. doi: 10.4049/jimmunol.2200261.
    >> Share

    J Infect

  34. RICHARDS A, Muddassir M, Sampson F, MacLachlan L, et al
    Evaluation of pre-hospital COVID-19 rapid antigen tests by paramedics and their use in a direct admission pathway: Pre-Hospital COVID-19 rapid antigen tests.
    J Infect. 2022 Jun 18. pii: S0163-4453(22)00371.
    >> Share

  35. PENG H, Wu X, Xiong S, Li C, et al
    Gout and susceptibility and severity of COVID-19: a bidirectional Mendelian randomization analysis.
    J Infect. 2022 Jun 17. pii: S0163-4453(22)00366.
    >> Share

  36. HATCHER J, Gil E, Storey N, Brown JR, et al
    Reactivation/relapse of SARS-CoV-2 in a child following haematopoietic stem cell transplantation, confirmed by whole genome sequencing, following apparent viral clearance.
    J Infect. 2022 Jun 17. pii: S0163-4453(22)00367.
    >> Share

  37. COCHINO AV, Farkas OM, Ioan A
    Pediatric Patients with Immune-Mediated Diseases on Immunosuppressants Have Low Risk of Severe COVID-19 and No Increase in Flare Rate after SARS CoV-2 Exposure.
    J Infect. 2022 Jun 17. pii: S0163-4453(22)00365.
    >> Share

  38. LAZARUS R, Taucher C, Brown C, Corbic I, et al
    Safety and immunogenicity of the inactivated whole-virus adjuvanted vaccine VLA2001: a randomized, dose escalation, double-blind phase 1/2 clinical trial in healthy adults.
    J Infect. 2022 Jun 16. pii: S0163-4453(22)00361.
    >> Share

  39. WORSLEY CM, van der Mescht MA, Hoffman D, Meyer PWA, et al
    Decline in antibody responses to SARS-CoV-2 post-vaccination poses a risk to health care workers.
    J Infect. 2022 Jun 12. pii: S0163-4453(22)00360.
    >> Share

  40. KANG SW, Kim JY, Park H, Lim SY, et al
    Comparison of outward transmission potential between vaccinated and partially vaccinated or unvaccinated individuals with the SARS-CoV-2 delta variant infection.
    J Infect. 2022 Jun 12. pii: S0163-4453(22)00355.
    >> Share

  41. GABBI C, Renieri A, Strandvik B
    Geographical distribution of cystic fibrosis carriers as population genetic determinant of COVID-19 spread and fatality in 37 countries.
    J Infect. 2022 Jun 11. pii: S0163-4453(22)00359.
    >> Share

  42. SANG L, Cheng B, Yu Y, Xi Y, et al
    The efficacy and safety of IBI314 on Delta and Omicron variant of SARS-CoV-2: first-in-human evidence.
    J Infect. 2022 Jun 9. pii: S0163-4453(22)00354.
    >> Share

  43. XU QY, Li QL, Jia ZJ, Wu MJ, et al
    Is the fourth COVID-19 vaccine dose urgently needed? Revelation from a prospective cohort study.
    J Infect. 2022 Jun 9. pii: S0163-4453(22)00356.
    >> Share

  44. LV P, Hu B, Hua R, Zhang J, et al
    A novelly designed protein antagonist confers potent neutralization against SARS-COV-2 variants of concern.
    J Infect. 2022 Jun 3. pii: S0163-4453(22)00350.
    >> Share

  45. WANG B, Fu J, Lu A, Yang J, et al
    Suitability assessment of CD24 targeted-therapy in the cancer patients with COVID-19: Preliminary results from pan-cancer.
    J Infect. 2022 May 31. pii: S0163-4453(22)00337.
    >> Share

  46. GUO Z, Zhao S, Ryu S, Mok CKP, et al
    Superspreading potential of infection seeded by the SARS-CoV-2 Omicron BA.1 variant in South Korea.
    J Infect. 2022 Jun 1. pii: S0163-4453(22)00344.
    >> Share

  47. STANKUNAS M, Dziugys A, Skarbalius G, Misiulis E, et al
    J Infect. 2022 Jun 1. pii: S0163-4453(22)00340.
    >> Share

  48. LI Y, Guo Y, Duan Y
    Changes in Streptococcus pneumoniae infection in children before and after the COVID-19 pandemic in Zhengzhou, China.
    J Infect. 2022 Jun 1. pii: S0163-4453(22)00348.
    >> Share

  49. GIANNONE D, Vecchione MB, Czernikier A, Polo ML, et al
    SARS-CoV-2 humoral and cellular immune responses in COVID-19 convalescent individuals with HIV.
    J Infect. 2022 May 27. pii: S0163-4453(22)00315.
    >> Share

  50. ZOU P, Li G, Ge X, Wang J, et al
    Lymphocyte subset changes in neonates with respiratory syncytial virus pneumonia.
    J Infect. 2022;85:334-363.
    >> Share

  51. KAMALI Z, Vonk JM, Thio CHL, Vaez A, et al
    A Mendelian randomization cytokine screen reveals IL-13 as causal factor in risk of severe COVID-19.
    J Infect. 2022 May 23. pii: S0163-4453(22)00313.
    >> Share

    J Virol

  52. CHAN M, Tiwary M, Wu HL, Tailor N, et al
    Pandemic 1918 Influenza Virus Does Not Cause Lethal Infection in Rhesus or Cynomolgus Macaques.
    J Virol. 2022 Aug 4:e0072822. doi: 10.1128/jvi.00728.
    >> Share

  53. ABBADI N, Nagashima K, Pena-Briseno A, Ross TM, et al
    Differential Recognition of Computationally Optimized H3 Hemagglutinin Influenza Vaccine Candidates by Human Antibodies.
    J Virol. 2022 Aug 2:e0089622. doi: 10.1128/jvi.00896.
    >> Share

  54. SCHWAB LSU, Londrigan SL, Brooks AG, Hurt AC, et al
    Induction of Interferon-Stimulated Genes Correlates with Reduced Growth of Influenza A Virus in Lungs after RIG-I Agonist Treatment of Ferrets.
    J Virol. 2022 Aug 2:e0055922. doi: 10.1128/jvi.00559.
    >> Share

  55. XU C, Zhang N, Yang Y, Liang W, et al
    Immune Escape Adaptive Mutations in Hemagglutinin Are Responsible for the Antigenic Drift of Eurasian Avian-Like H1N1 Swine Influenza Viruses.
    J Virol. 2022 Aug 2:e0097122. doi: 10.1128/jvi.00971.
    >> Share

  56. VAN OOSTEN L, Yan K, Rawle DJ, Le TT, et al
    An S1-Nanoparticle Vaccine Protects against SARS-CoV-2 Challenge in K18-hACE2 Mice.
    J Virol. 2022 Jun 29:e0084422. doi: 10.1128/jvi.00844.
    >> Share

  57. JIANG C, Li L, Xue M, Zhao L, et al
    Long-Term Expanding Porcine Airway Organoids Provide Insights into the Pathogenesis and Innate Immunity of Porcine Respiratory Coronavirus Infection.
    J Virol. 2022 Jun 28:e0073822. doi: 10.1128/jvi.00738.
    >> Share

  58. DIEBOLD O, Gonzalez V, Venditti L, Sharp C, et al
    Using Species a Rotavirus Reverse Genetics to Engineer Chimeric Viruses Expressing SARS-CoV-2 Spike Epitopes.
    J Virol. 2022 Jun 27:e0048822. doi: 10.1128/jvi.00488.
    >> Share

    J Virol Methods

  59. AZEEM S, Guo B, Sun D, Killian ML, et al
    Evaluation of PCR-Based Hemagglutinin Subtyping as a Tool to aid in Surveillance of Avian Influenza viruses in Migratory Wild Birds.
    J Virol Methods. 2022 Aug 2:114594. doi: 10.1016/j.jviromet.2022.114594.
    >> Share


    Sickle Cell Trait Associated With Kidney Failure and COVID-19 Death.
    JAMA. 2022;328:415.
    >> Share

    Maternal Death Rate Increased During Early COVID-19 Pandemic.
    JAMA. 2022;328:415.
    >> Share

  62. GENZEN JR, Rychert J, George TI
    Integrity of SARS-CoV-2 Laboratory-Developed Tests.
    JAMA. 2022;328:478.
    >> Share

  63. ADASHI EY, Cohen G
    Integrity of SARS-CoV-2 Laboratory-Developed Tests-Reply.
    JAMA. 2022;328:478-479.
    >> Share

  64. RUBIN R
    COVID-19 Boosters This Fall to Include Omicron Antigen, but Questions Remain About Its Value.
    JAMA. 2022 Jul 8. pii: 2794259. doi: 10.1001/jama.2022.11252.
    >> Share


  65. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
    Lancet. 2022;400:359-368.
    >> Share

    Violence against health workers rises during COVID-19.
    Lancet. 2022;400:348.
    >> Share

  67. MEHTA P, Titanji BK
    Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality.
    Lancet. 2022;400:338-339.
    >> Share

    Perilous two-tier COVID-19 global vaccine roll-out.
    Lancet. 2022 Jul 11. pii: S0140-6736(22)01284.
    >> Share

  69. DALZIEL SR, Haskell L, O'Brien S, Borland ML, et al
    Lancet. 2022;400:392-406.
    >> Share

    MMWR Morb Mortal Wkly Rep

  70. HAUSE AM, Baggs J, Marquez P, Abara WE, et al
    Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged >/=50 Years - United States, March 29, 2022-July 10, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:971-976.
    >> Share

    N Engl J Med

  71. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Updated Covid-19 Vaccines and a Look at Monkeypox.
    N Engl J Med. 2022;387:e16.
    >> Share

  72. HAMMOND J, Bao W, Simon-Campos A
    Nirmatrelvir for Nonhospitalized Adults with Covid-19. Reply.
    N Engl J Med. 2022;387.
    >> Share

  73. MORRIS AM, Lee TC
    Nirmatrelvir for Nonhospitalized Adults with Covid-19.
    N Engl J Med. 2022;387.
    >> Share

  74. CHEN BS, Hung CH, Wei JC
    Nirmatrelvir for Nonhospitalized Adults with Covid-19.
    N Engl J Med. 2022;387.
    >> Share


  75. SHAPIRO JP, Anspacher M, Madrigal V, Lantos JD, et al
    Disposition Decisions in Cases of Medical Complexity and Health Inequity.
    Pediatrics. 2022;150.
    >> Share

  76. DROGALIS-KIM D, Kramer C, Duran S
    Ongoing Dizziness Following Acute COVID-19 Infection: A Single Center Pediatric Case Series.
    Pediatrics. 2022;150.
    >> Share

  77. KARATZIOS C, Scuccimarri R, Chedeville G, Basfar W, et al
    Multisystem Inflammatory Syndrome Following SARS-CoV-2 Vaccination in Two Children.
    Pediatrics. 2022 May 26. pii: 188099. doi: 10.1542/peds.2021-055956.
    >> Share

  78. BARTON HJ, Werner NE, Morgen M, DeMuri GP, et al
    Task Analysis of In-Home SARS-CoV-2 Rapid Antigen Testing by Families.
    Pediatrics. 2022;150.
    >> Share

  79. NYGAARD U, Holm M, Dungu KHS, Matthesen AT, et al
    Risk of Myopericarditis After COVID-19 Vaccination in Danish Children Aged 5-11 Years.
    Pediatrics. 2022 May 19. pii: 188025. doi: 10.1542/peds.2022-057508.
    >> Share

  80. HAUSE AM, Shay DK, Klein NP, Abara WE, et al
    Safety of COVID-19 Vaccination in US Children Ages 5-11 Years.
    Pediatrics. 2022 May 18. pii: 188023. doi: 10.1542/peds.2022-057313.
    >> Share

  81. OLIVER SE, Wallace M, Link-Gelles R
    COVID-19 Vaccines: Safe and Effective in Children Ages 5-11 Years.
    Pediatrics. 2022 May 18. pii: 188024. doi: 10.1542/peds.2022-057314.
    >> Share

  82. BRUNS N, Willemsen L, Stang A, Kowall B, et al
    Pediatric Intensive Care Unit Admissions After Adolescent Suicide Attempts During the Pandemic.
    Pediatrics. 2022 May 10. pii: 187005. doi: 10.1542/peds.2021-055973.
    >> Share

  83. WOODRUFF RC, Campbell AP, Taylor CA, Chai SJ, et al
    Risk Factors for Severe COVID-19 in Children.
    Pediatrics. 2022;149.
    >> Share

    PLoS Comput Biol

  84. BLUMBERG S, Lu P, Kwan AT, Hoover CM, et al
    Modeling scenarios for mitigating outbreaks in congregate settings.
    PLoS Comput Biol. 2022;18:e1010308.
    >> Share

  85. JIMENEZ-GUARDENO JM, Ortega-Prieto AM, Menendez Moreno B, Maguire TJA, et al
    Drug repurposing based on a quantum-inspired method versus classical fingerprinting uncovers potential antivirals against SARS-CoV-2.
    PLoS Comput Biol. 2022;18:e1010330.
    >> Share

    PLoS Med

  86. HERNANDEZ I, Dickson S, Tang S, Gabriel N, et al
    Disparities in distribution of COVID-19 vaccines across US counties: A geographic information system-based cross-sectional study.
    PLoS Med. 2022;19:e1004069.
    >> Share

  87. MASSARI M, Spila Alegiani S, Morciano C, Spuri M, et al
    Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study.
    PLoS Med. 2022;19:e1004056.
    >> Share

    PLoS One

  88. MUKKA M, Pesala S, Juutinen A, Virtanen MJ, et al
    Online searches of children's oseltamivir in public primary and specialized care: Detecting influenza outbreaks in Finland using dedicated databases for health care professionals.
    PLoS One. 2022;17:e0272040.
    >> Share

  89. HADDADIN Z, Spieker AJ, Rahman H, Rankin DA, et al
    Respiratory pathogens during the COVID-19 pandemic: Alterations in detection and seasonality in Nashville, Tennessee.
    PLoS One. 2022;17:e0270469.
    >> Share

  90. ATHAPATHU A, Navaratnam D, Doluweera M, Liyanage G, et al
    Child emotional and behavioral difficulties and parent stress during COVID-19 lockdown in Sri Lankan families.
    PLoS One. 2022;17:e0271757.
    >> Share

  91. MEHTA CC, Hagen KS, Rubtsova AA, Lahiri CD, et al
    Bone, Brain, Heart study protocol: A resilient nested, tripartite prospective cohort study of the role of estrogen depletion on HIV pathology.
    PLoS One. 2022;17:e0272608.
    >> Share

  92. LOW YL, Wong SY, Lee EKH, Muhammed MH, et al
    Prevalence of respiratory viruses among paediatric patients in acute respiratory illnesses in Malaysia.
    PLoS One. 2022;17:e0265288.
    >> Share

  93. HILLS PD, Clavin MVQ, Tufft MRA, Gobel MS, et al
    Video meeting signals: Experimental evidence for a technique to improve the experience of video conferencing.
    PLoS One. 2022;17:e0270399.
    >> Share

  94. CELLINI M, Pecoraro F, Rigby M, Luzi D, et al
    Comparative analysis of pre-Covid19 child immunization rates across 30 European countries and identification of underlying positive societal and system influences.
    PLoS One. 2022;17:e0271290.
    >> Share

  95. PSIHOGIOS A, Madampage C, Faught BE
    Contemporary nutrition-based interventions to reduce risk of infection among elderly long-term care residents: A scoping review.
    PLoS One. 2022;17:e0272513.
    >> Share

  96. BOWRA A, Saeed G, Gorodensky A, Kohler JC, et al
    An exploration of anti-corruption and health in international organizations.
    PLoS One. 2022;17:e0269203.
    >> Share

  97. SOLYMARI D, Kairu E, Czirjak R, Tarrosy I, et al
    The impact of COVID-19 on the livelihoods of Kenyan slum dwellers and the need for an integrated policy approach.
    PLoS One. 2022;17:e0271196.
    >> Share

  98. TOLEDO E, Dim S, Edri A, Greenshpan Y, et al
    Nanocomposite coatings for the prevention of surface contamination by coronavirus.
    PLoS One. 2022;17:e0272307.
    >> Share

  99. SHEN X
    Accessibility calculation and equality evaluation of medical facilities for COVID-19 pandemic treatment: A case study of the Wuhan metropolitan development zone.
    PLoS One. 2022;17:e0272458.
    >> Share

  100. STEPHENS AN, Trawley S, Ispanovic J, Lowrie S, et al
    Self-reported changes in aggressive driving within the past five years, and during COVID-19.
    PLoS One. 2022;17:e0272422.
    >> Share

  101. NAWA RK, Serpa Neto A, Lazarin AC, da Silva AK, et al
    Analysis of mobility level of COVID-19 patients undergoing mechanical ventilation support: A single center, retrospective cohort study.
    PLoS One. 2022;17:e0272373.
    >> Share

  102. ALSHAIKH FS, Godman B, Sindi ON, Seaton RA, et al
    Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0272375.
    >> Share

  103. KAN Y, Asada M, Uesawa Y
    Trends in reporting embolic and thrombotic events after COVID-19 vaccination: A retrospective, pharmacovigilance study.
    PLoS One. 2022;17:e0269268.
    >> Share

  104. ROHANI-RASAF M, Mirjalili K, Vatannejad A, Teimouri M, et al
    Are lipid ratios and triglyceride-glucose index associated with critical care outcomes in COVID-19 patients?
    PLoS One. 2022;17:e0272000.
    >> Share

  105. NUNGSARI M, Chuah HY, Flanders S
    Identity, trust, and the experiences of refugees during a COVID-19 lockdown.
    PLoS One. 2022;17:e0271977.
    >> Share

  106. ZHAO S, Chen L, Liu Y, Yu M, et al
    Deriving anti-epidemic policy from public sentiment: A framework based on text analysis with microblog data.
    PLoS One. 2022;17:e0270953.
    >> Share

  107. SHARIF N, Alzahrani KJ, Ahmed SN, Khan A, et al
    Genomic surveillance, evolution and global transmission of SARS-CoV-2 during 2019-2022.
    PLoS One. 2022;17:e0271074.
    >> Share

  108. KOSTER HRA, van Ommeren J, Tang CK, Bras N, et al
    Covid-19 restriction policies and shopping streets.
    PLoS One. 2022;17:e0267160.
    >> Share

  109. CICERALE A, Blanzieri E, Sacco K
    How does decision-making change during challenging times?
    PLoS One. 2022;17:e0270117.
    >> Share

  110. RAICHLE C, Borgmann S, Bausewein C, Rieg S, et al
    Hospitalized patients dying with SARS-CoV-2 infection-An analysis of patient characteristics and management in ICU and general ward of the LEOSS registry.
    PLoS One. 2022;17:e0271822.
    >> Share

  111. DO TD, Skornitzke S, Merle U, Kittel M, et al
    COVID-19 pneumonia: Prediction of patient outcome by CT-based quantitative lung parenchyma analysis combined with laboratory parameters.
    PLoS One. 2022;17:e0271787.
    >> Share

    Analysis of multi-strain infection of vaccinated and recovered population through epidemic model: Application to COVID-19.
    PLoS One. 2022;17:e0271446.
    >> Share

  113. YUSUF A, Wright N, Steiman M, Gonzalez M, et al
    Factors associated with resilience among children and youths with disability during the COVID-19 pandemic.
    PLoS One. 2022;17:e0271229.
    >> Share

  114. LEE HW, Leng CH, Chan TC
    Determinants of personal vaccination hesitancy before and after the mid-2021 COVID-19 outbreak in Taiwan.
    PLoS One. 2022;17:e0270349.
    >> Share

  115. RASHIDI HH, Pepper J, Howard T, Klein K, et al
    Comparative performance of two automated machine learning platforms for COVID-19 detection by MALDI-TOF-MS.
    PLoS One. 2022;17:e0263954.
    >> Share

  116. JAHAN FA, Zviedrite N, Gao H, Ahmed F, et al
    Causes, characteristics, and patterns of prolonged unplanned school closures prior to the COVID-19 pandemic-United States, 2011-2019.
    PLoS One. 2022;17:e0272088.
    >> Share

  117. KIM KM, Evans DS, Jacobson J, Jiang X, et al
    Rapid prediction of in-hospital mortality among adults with COVID-19 disease.
    PLoS One. 2022;17:e0269813.
    >> Share

  118. TABATABAI J, Schnitzler P, Prifert C, Schiller M, et al
    Parainfluenza virus infections in patients with hematological malignancies or stem cell transplantation: Analysis of clinical characteristics, nosocomial transmission and viral shedding.
    PLoS One. 2022;17:e0271756.
    >> Share

  119. GYCHKA SG, Brelidze TI, Kuchyn IL, Savchuk TV, et al
    Placental vascular remodeling in pregnant women with COVID-19.
    PLoS One. 2022;17:e0268591.
    >> Share

  120. GOOLDY M, Roux CM, LaRosa SP, Spaulding N, et al
    Removal of clinically relevant SARS-CoV-2 variants by an affinity resin containing Galanthus nivalis agglutinin.
    PLoS One. 2022;17:e0272377.
    >> Share

  121. VAN EMPELEN P, Preuhs K, Bakker LA, Buursma P, et al
    Improving behavioural compliance with the COVID-19 precautionary measures by means of innovative communication strategies: Social experimental studies.
    PLoS One. 2022;17:e0272001.
    >> Share

  122. MILES A, Andiappan M, Upenieks L, Orfanidis C, et al
    Using prosocial behavior to safeguard mental health and foster emotional well-being during the COVID-19 pandemic: A registered report of a randomized trial.
    PLoS One. 2022;17:e0272152.
    >> Share

  123. FRISCHE A, Brooks PT, Gybel-Brask M, Saekmose SG, et al
    Optimization and evaluation of a live virus SARS-CoV-2 neutralization assay.
    PLoS One. 2022;17:e0272298.
    >> Share

  124. SADDIK B, Awad MA, Al-Bluwi N, Hussein A, et al
    The impact of environmental and climate parameters on the incidence and mortality of COVID-19 in the six Gulf Cooperation Council countries: A cross-country comparison study.
    PLoS One. 2022;17:e0269204.
    >> Share

  125. TRAJMAN A, Lachapelle-Chisholm S, Zikos T, Werneck GL, et al
    Efficacy and effectiveness of SARS-CoV-2 vaccines for death prevention: A protocol for a systematic review and meta-analysis.
    PLoS One. 2022;17:e0265414.
    >> Share

  126. LAZZARINI N, Filippoupolitis A, Manzione P, Eleftherohorinou H, et al
    A machine learning model on Real World Data for predicting progression to Acute Respiratory Distress Syndrome (ARDS) among COVID-19 patients.
    PLoS One. 2022;17:e0271227.
    >> Share

  127. MAPALA L, Bekker A, Dramowski A
    Evaluating the appropriateness of laboratory testing and antimicrobial use in South African children hospitalized for community-acquired infections.
    PLoS One. 2022;17:e0272119.
    >> Share

  128. SABZIAN-MOLAEI F, Nasiri Khalili MA, Sabzian-Molaei M, Shahsavarani H, et al
    Urtica dioica Agglutinin: A plant protein candidate for inhibition of SARS-COV-2 receptor-binding domain for control of Covid19 Infection.
    PLoS One. 2022;17:e0268156.
    >> Share

  129. MAO L, Huang Y, Zhang X, Li S, et al
    ARIMA model forecasting analysis of the prices of multiple vegetables under the impact of the COVID-19.
    PLoS One. 2022;17:e0271594.
    >> Share

  130. LUBETKIN EI, Long D, Haagsma JA, Janssen MF, et al
    Health inequities as measured by the EQ-5D-5L during COVID-19: Results from New York in healthy and diseased persons.
    PLoS One. 2022;17:e0272252.
    >> Share

  131. SAH SK, Shariff A, Pathakamuri N, Ramaswamy S, et al
    Antifungal therapy in the management of fungal secondary infections in COVID-19 patients: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0271795.
    >> Share

  132. VILLARREAL-ZEGARRA D, Reategui-Rivera CM, Sabastizagal-Vela I, Burgos-Flores MA, et al
    Policies on mental health in the workplace during the COVID-19 pandemic: A scoping review.
    PLoS One. 2022;17:e0272296.
    >> Share

  133. UELAND GA, Ernes T, Vonheim Madsen T, Husebye ES, et al
    Fear of Covid 19 during the third wave of infection in Norwegian patients with type 1 diabetes.
    PLoS One. 2022;17:e0272133.
    >> Share

  134. BALAOURAS G, Eusebi P, Kostoulas P
    Systematic review and meta-analysis of the effect of ABO blood group on the risk of SARS-CoV-2 infection.
    PLoS One. 2022;17:e0271451.
    >> Share

  135. PRENDERGAST C, Robinson J, Caya C, Perez Trejo ME, et al
    Urgent air transfers for acute respiratory infections among children from Northern Canada, 2005-2014.
    PLoS One. 2022;17:e0272154.
    >> Share

  136. CERBULO-VAZQUEZ A, Garcia-Espinosa M, Briones-Garduno JC, Arriaga-Pizano L, et al
    The percentage of CD39+ monocytes is higher in pregnant COVID-19+ patients than in nonpregnant COVID-19+ patients.
    PLoS One. 2022;17:e0264566.
    >> Share

  137. ABO EL HASSAN FS, Hamed R, Ismail EA, Ezzat SM, et al
    Optimum stratum boundaries and sample sizes for Covid-19 data in Egypt.
    PLoS One. 2022;17:e0271220.
    >> Share

  138. MOHAMMADI S, Moradi P, Firouzabadi SM, Jafari G, et al
    The footprint of campaign strategies in Farsi Twitter: A case for 2021 Iranian presidential election.
    PLoS One. 2022;17:e0270822.
    >> Share

  139. KADYROVA I, Yegorov S, Negmetzhanov B, Kolesnikova Y, et al
    High SARS-CoV-2 seroprevalence in Karaganda, Kazakhstan before the launch of COVID-19 vaccination.
    PLoS One. 2022;17:e0272008.
    >> Share

  140. ORENDACOVA M, Kvasnak E, Vranova J
    Effect of neurofeedback therapy on neurological post-COVID-19 complications (A pilot study).
    PLoS One. 2022;17:e0271350.
    >> Share

  141. CHALHOUB Z, Koubeissy H, Fares Y, Abou-Abbas L, et al
    Fear and death anxiety in the shadow of COVID-19 among the Lebanese population: A cross-sectional study.
    PLoS One. 2022;17:e0270567.
    >> Share

  142. ROBINS WP, Mekalanos JJ
    Covariance predicts conserved protein residue interactions important for the emergence and continued evolution of SARS-CoV-2 as a human pathogen.
    PLoS One. 2022;17:e0270276.
    >> Share

  143. AGYEI SK, Owusu Junior P, Bossman A, Asafo-Adjei E, et al
    Spillovers and contagion between BRIC and G7 markets: New evidence from time-frequency analysis.
    PLoS One. 2022;17:e0271088.
    >> Share

  144. MCFADDEN S, Guille S, Daly-Lynn J, O'Neill B, et al
    Academic, clinical and personal experiences of undergraduate healthcare students during the COVID-19 pandemic: A prospective cohort study.
    PLoS One. 2022;17:e0271873.
    >> Share

  145. DUGGAL B, Duggal M, Panch A, Chourase M, et al
    Using a national level cross-sectional study to develop a Hospital Preparedness Index (HOSPI) for Covid-19 management: A case study from India.
    PLoS One. 2022;17:e0269842.
    >> Share

  146. TOLOSSA T, Wakuma B, Ayala D, Seyoum D, et al
    Incidence and predictors of death from COVID-19 among patients admitted to treatment center of Wollega University Referral Hospital, Western Ethiopia: A retrospective cohort study.
    PLoS One. 2022;17:e0267827.
    >> Share

  147. BRANDT MD, Ghozy SA, Kallmes DF, McDonald RJ, et al
    Comparison of citation rates between Covid-19 and non-Covid-19 articles across 24 major scientific journals.
    PLoS One. 2022;17:e0271071.
    >> Share

  148. AVULA R, Nguyen PH, Ashok S, Bajaj S, et al
    Disruptions, restorations and adaptations to health and nutrition service delivery in multiple states across India over the course of the COVID-19 pandemic in 2020: An observational study.
    PLoS One. 2022;17:e0269674.
    >> Share

  149. REBHOLZ H, Braun RJ, Saha T, Harzer O, et al
    Longitudinal monitoring of SARS-CoV-2 spike protein-specific antibody responses in Lower Austria.
    PLoS One. 2022;17:e0271382.
    >> Share

  150. VITRO C, Clark DA, Sherman C, Heitzeg MM, et al
    Attitudes about police and race in the United States 2020-2021: Mean-level trends and associations with political attitudes, psychiatric problems, and COVID-19 outcomes.
    PLoS One. 2022;17:e0271954.
    >> Share

  151. HWANG J, Su MH, Jiang X, Lian R, et al
    Vaccine discourse during the onset of the COVID-19 pandemic: Topical structure and source patterns informing efforts to combat vaccine hesitancy.
    PLoS One. 2022;17:e0271394.
    >> Share

    Proc Natl Acad Sci U S A

  152. KRYMOVA E, Bejar B, Thanou D, Sun T, et al
    Trend estimation and short-term forecasting of COVID-19 cases and deaths worldwide.
    Proc Natl Acad Sci U S A. 2022;119:e2112656119.
    >> Share

  153. BANKER M, Miller M, Voichek G, Goor D, et al
    Prosocial nudges and visual indicators increase social distancing, but authoritative nudges do not.
    Proc Natl Acad Sci U S A. 2022;119:e2116156119.
    >> Share

  154. GAMBETTA D, Morisi D
    COVID-19 infection induces higher trust in strangers.
    Proc Natl Acad Sci U S A. 2022;119:e2116818119.
    >> Share

  155. CHANDRA S
    Data analysis of viral complementary DNA/RNA sequences for low-frequency intrahost-single nucleotide variants in COVID-19.
    Proc Natl Acad Sci U S A. 2022;119:e2205269119.
    >> Share

  156. BASHOR L, Gagne RB, Bosco-Lauth A, Bowen RA, et al
    Reply to Chandra: Severe Acute Respiratory Syndrome-Coronavirus-2 variant analysis reveals within-host selection of intra-host single nucleotide variants.
    Proc Natl Acad Sci U S A. 2022;119:e2206919119.
    >> Share

  157. LUO G, Zhang J, Lin L, Mignot EJ, et al
    Characterization of T cell receptors reactive to HCRTNH2, pHA273-287, and NP17-31 in control and narcolepsy patients.
    Proc Natl Acad Sci U S A. 2022;119:e2205797119.
    >> Share

  158. MELIN JL, Correll SJ
    Preventing soft skill decay among early-career women in STEM during COVID-19: Evidence from a longitudinal intervention.
    Proc Natl Acad Sci U S A. 2022;119:e2123105119.
    >> Share

  159. ZHANG Y, Lu M, Mahesh KC, Kim E, et al
    A highly efficacious live attenuated mumps virus-based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spike.
    Proc Natl Acad Sci U S A. 2022;119:e2201616119.
    >> Share

  160. IWAMURA C, Hirahara K, Kiuchi M, Ikehara S, et al
    Elevated Myl9 reflects the Myl9-containing microthrombi in SARS-CoV-2-induced lung exudative vasculitis and predicts COVID-19 severity.
    Proc Natl Acad Sci U S A. 2022;119:e2203437119.
    >> Share

  161. SOLOMON MD, Escobar GJ, Lu Y, Schlessinger D, et al
    Risk of severe COVID-19 infection among adults with prior exposure to children.
    Proc Natl Acad Sci U S A. 2022;119:e2204141119.
    >> Share


  162. MIMURA W, Ishiguro C, Fukuda H
    Influenza vaccine effectiveness against hospitalization during the 2018/2019 season among older persons aged>/=75years in Japan: The LIFE-VENUS Study.
    Vaccine. 2022 Jul 15. pii: S0264-410X(22)00852.
    >> Share


  163. WANG T, Wei F, Jiang Z, Song J, et al
    Influenza virus NS1 interacts with 14-3-3epsilon to antagonize the production of RIG-I-mediated type I interferons.
    Virology. 2022;574:47-56.
    >> Share

  164. OH J, Subbiah J, Kim KH, Park BR, et al
    Impact of hemagglutination activity and M2e immunity on conferring protection against influenza viruses.
    Virology. 2022;574:37-46.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016